Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Edurant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,686Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NICE says yes to GSK's Cabenuva, new option for HIV patients
    NICE says yes to GSK's Cabenuva, new option for HIV patients

    19 Nov 2021

    // K. Dunleavy FIERCEPHARMA

    https://www.fiercepharma.com/pharma/nice-gives-a-thumbs-up-to-gsk-s-cabenuva-giving-hiv-patients-attractive-treatment-option

    K. Dunleavy FIERCEPHARMA
    19 Nov 2021
    Share Share
    ViiV sees first global approval of Cabenuva in Canada
    ViiV sees first global approval of Cabenuva in Canada

    23 Mar 2020

    // Anna Smith PHARMATIMES

    http://www.pharmatimes.com/news/viiv_sees_first_global_approval_of_cabenuva_in_canada_1329795

    Anna Smith PHARMATIMES
    23 Mar 2020
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Odefsey 208351 (Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Alafenamide Fumarate )Tablets
    FDA Confirms Paragraph IV Patent Challenge of Odefsey 208351 (Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Alafenamide Fumarate )Tablets

    07 Jan 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-odefsey-208351-emtricitabine-rilpivirine-hydrochloride-and-tenofovir-alafenamide-fumarate-tablets-1578398200.pdf

    FDA
    07 Jan 2020
    Share Share
    FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues
    FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues

    24 Dec 2019

    // Amber Tong ENDPTS

    https://endpts.com/fda-slams-gsks-monthly-hiv-injectable-with-crl-citing-manufacturing-issues/

    Amber Tong ENDPTS
    24 Dec 2019
    Share Share
    J&J-backed AIDS film picked up by Verizon Media
    J&J-backed AIDS film picked up by Verizon Media

    10 May 2019

    // Beth Snyder Bulik FIERCE PHARMA

    https://www.fiercepharma.com/marketing/j-j-sponsored-film-about-first-aids-ward-san-francisco-picked-up-for-broader-distribution

    Beth Snyder Bulik FIERCE PHARMA
    10 May 2019
    Share Share
    Prescription med: new or extended uses, new combinations of registered medicines
    Prescription med: new or extended uses, new combinations of registered medicines

    09 Jul 2018

    // TGA

    https://www.tga.gov.au/prescription-medicines-new-or-extended-uses-registered-medicines

    TGA
    09 Jul 2018
    Share Share